BALTIMORE, Md.—The novel therapeutic agent PA65020 (enteric-coated aspirin plus immediate-release omeprazole) significantly reduced gastrointestinal mucosal damage after 28 days of treatment compared ...
Expert Rev Cardiovasc Ther. 2013;11(3):365-379. Obesity, diabetes, aging, conditions associated with high platelet regenerations, some genotypes, or some EC formulations are settings where a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback